BCRX
#1851
BioCryst Pharmaceuticals, Inc. - Common Stock
9.8 2 USD
-0.01%
Market Price
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
-0.51%
Changement Mensuel
+3.70%
Evolution sur 6 mois
+13.53%
Changement Annuel
+17.32%
Clôture Précédente
9.8 7
Open
9.8 2
Low
9.8 2
High
9.8 2
Volume
139
Financials
- Market Capitalization 2.51 B
- Employee 435
- Founded 1986
- CEO Jon P. Stonehouse
- Website www.biocryst.com
- Headquarter Delaware, United States
- FIGI BBG000BLYWX6
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
6.45
ratio cours/chiffre d'affaires
1.95
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 1826 |  VRDN Viridian Therapeutics, Inc. - Common Stock | 23.08 USD | -3.35% | -5.22% | +18.06% | +2.81% | 2.61 B USD | ||
| 1846 |  RARE Ultragenyx Pharmaceutical Inc. - Common Stock | 25.61 USD | -2.48% | -0.54% | +2.28% | -16.03% | 2.52 B USD | ||
| 1857 |  PGEN Precigen, Inc. - Common Stock | 6.95 USD | -3.34% | -2.80% | +29.18% | +54.79% | 2.49 B USD | ||
| 1862 |  NKTR Nektar Therapeutics - Common Stock | 72.52 USD | -2.72% | -0.67% | +3.57% | -1.02% | 2.48 B USD |